Analysis

Purdue's Ch. 11 Plan Hangs On Sackler Liability Question

By Vince Sullivan (March 16, 2021, 7:35 PM EDT) -- The viability of Purdue Pharma's much anticipated Chapter 11 plan hangs on whether creditors are willing to release the Sackler family from what could be heaps of liability in exchange for their $4.5 billion in contributions that would fund creditor recoveries and opioid abatement programs, experts told Law360....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!